These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35623354)

  • 41. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.
    Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC
    Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-CRISPR-Associated Proteins Are Crucial Repressors of Anti-CRISPR Transcription.
    Stanley SY; Borges AL; Chen KH; Swaney DL; Krogan NJ; Bondy-Denomy J; Davidson AR
    Cell; 2019 Sep; 178(6):1452-1464.e13. PubMed ID: 31474367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting of temperate phages drives loss of type I CRISPR-Cas systems.
    Rollie C; Chevallereau A; Watson BNJ; Chyou TY; Fradet O; McLeod I; Fineran PC; Brown CM; Gandon S; Westra ER
    Nature; 2020 Feb; 578(7793):149-153. PubMed ID: 31969710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mobile element warfare via CRISPR and anti-CRISPR in Pseudomonas aeruginosa.
    León LM; Park AE; Borges AL; Zhang JY; Bondy-Denomy J
    Nucleic Acids Res; 2021 Feb; 49(4):2114-2125. PubMed ID: 33544853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predominance of Single Prophage Carrying a CRISPR/cas System in "Candidatus Liberibacter asiaticus" Strains in Southern China.
    Zheng Z; Bao M; Wu F; Chen J; Deng X
    PLoS One; 2016; 11(1):e0146422. PubMed ID: 26741827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-CRISPR prediction using deep learning reveals an inhibitor of Cas13b nucleases.
    Wandera KG; Alkhnbashi OS; Bassett HVI; Mitrofanov A; Hauns S; Migur A; Backofen R; Beisel CL
    Mol Cell; 2022 Jul; 82(14):2714-2726.e4. PubMed ID: 35649413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins.
    Yang L; Zhang Y; Yin P; Feng Y
    RNA Biol; 2021 Nov; 18(sup2):562-573. PubMed ID: 34606423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems.
    Foster K; Kalter J; Woodside W; Terns RM; Terns MP
    RNA Biol; 2019 Apr; 16(4):449-460. PubMed ID: 29995577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-CRISPR proteins: Counterattack of phages on bacterial defense (CRISPR/Cas) system.
    Chaudhary K; Chattopadhyay A; Pratap D
    J Cell Physiol; 2018 Jan; 233(1):57-59. PubMed ID: 28247934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Campylobacter bacteriophage DA10: an excised temperate bacteriophage targeted by CRISPR-cas.
    Hooton S; D'Angelantonio D; Hu Y; Connerton PL; Aprea G; Connerton IF
    BMC Genomics; 2020 Jun; 21(1):400. PubMed ID: 32532247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs.
    Trasanidou D; Gerós AS; Mohanraju P; Nieuwenweg AC; Nobrega FL; Staals RHJ
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insights into the inhibition of type I-F CRISPR-Cas system by a multifunctional anti-CRISPR protein AcrIF24.
    Yang L; Zhang L; Yin P; Ding H; Xiao Y; Zeng J; Wang W; Zhou H; Wang Q; Zhang Y; Chen Z; Yang M; Feng Y
    Nat Commun; 2022 Apr; 13(1):1931. PubMed ID: 35411005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disarming of type I-F CRISPR-Cas surveillance complex by anti-CRISPR proteins AcrIF6 and AcrIF9.
    Kupcinskaite E; Tutkus M; Kopūstas A; Ašmontas S; Jankunec M; Zaremba M; Tamulaitiene G; Sinkunas T
    Sci Rep; 2022 Sep; 12(1):15548. PubMed ID: 36109551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Guide-bound structures of an RNA-targeting A-cleaving CRISPR-Cas13a enzyme.
    Knott GJ; East-Seletsky A; Cofsky JC; Holton JM; Charles E; O'Connell MR; Doudna JA
    Nat Struct Mol Biol; 2017 Oct; 24(10):825-833. PubMed ID: 28892041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
    Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structures and Strategies of Anti-CRISPR-Mediated Immune Suppression.
    Wiegand T; Karambelkar S; Bondy-Denomy J; Wiedenheft B
    Annu Rev Microbiol; 2020 Sep; 74():21-37. PubMed ID: 32503371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CRISPR RNA and anti-CRISPR protein binding to the
    Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
    J Biol Chem; 2018 Feb; 293(8):2744-2754. PubMed ID: 29348170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction and Elimination of Prophages Using CRISPR Interference.
    Cornuault JK; Moineau S
    CRISPR J; 2021 Aug; 4(4):549-557. PubMed ID: 34406037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting.
    Goldberg GW; Jiang W; Bikard D; Marraffini LA
    Nature; 2014 Oct; 514(7524):633-7. PubMed ID: 25174707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.